Get started
Author

Ben‐Gang Zhou

Observed names: Ben-Gang Zhou, BenGang Zhou, Bengang Zhou
Observed institutions: China Three Gorges University, Dalian Medical University, Hubei Polytechnic University, Northern Jiangsu People's Hospital, Huangshi Central Hospital, Yangzhou University
ORCID: 0000-0001-6096-3034
Observed ORCID: 0000-0001-6096-3034
OpenAlex ID: A5101733434
Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis with trial sequential analysis
2019 · Ben‐Gang Zhou, Ling‐Xiao Chen, et al. · Helicobacter · 82
Association of MASLD with the risk of extrahepatic cancers: A systematic review and meta‐analysis of 18 cohort studies
2024 · Ben‐Gang Zhou, Xin Jiang, et al. · European Journal of Clinical Investigation · 50
Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta‐analysis of observational studies
2019 · Ben‐Gang Zhou, Huai‐Jie Yang, et al. · Helicobacter · 50
Vonoprazan‐amoxicillin dual therapy versus bismuth‐containing quadruple therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis
2023 · Ben‐Gang Zhou, Xin Jiang, et al. · Helicobacter · 46
Association Between Non-alcoholic Fatty Liver Disease and Risk of Stroke: A Systematic Review and Meta-Analysis
2022 · Meng Wang, Ben-Gang Zhou, et al. · Frontiers in Cardiovascular Medicine · 34
PDF
Effect of enhanced patient instructions on Helicobacter pylori eradication: A systematic review and meta‐analysis of randomized controlled trials
2022 · Ben‐Gang Zhou, Xue‐Liang Yan, et al. · Helicobacter · 25
A systematic review and meta-analysis of cohort studies on the potential association between NAFLD/MAFLD and risk of incident atrial fibrillation
2023 · Ben‐Gang Zhou, Sheng-Yong Ju, et al. · Frontiers in Endocrinology · 24
Is Helicobacter pylori infection associated with pancreatic cancer? A systematic review and meta-analysis of observational studies
2023 · Ben-Gang Zhou, Yu-Zhou Mei, et al. · Therapeutic Advances in Chronic Disease · 23
Vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis of randomized controlled trials
2023 · Ben-Gang Zhou, Yu-Zhou Mei, et al. · Saudi Journal of Gastroenterology · 22
High-dose dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis with trial sequential analysis
2023 · Ben-Gang Zhou, Yu-Zhou Mei, et al. · Therapeutic Advances in Gastroenterology · 22
PDF
Intestinal metaplasia key molecules and UPP1 activation via Helicobacter pylori /NF-kB: drivers of malignant progression in gastric cancer
2024 · Xuyu Chen, Bengang Zhou, et al. · Cancer Cell International · 21
PDF
Association between metabolic dysfunction-associated steatotic liver disease and risk of colorectal cancer or colorectal adenoma: an updated meta-analysis of cohort studies
2024 · Jian-Feng Zhao, Ben-Gang Zhou, et al. · Frontiers in Oncology · 17
PDF
Association between inflammatory bowel disease and risk of incident prostate cancer: a systematic review and meta-analysis of cohort studies
2023 · Ben‐Gang Zhou, Qi Yu, et al. · International Journal of Colorectal Disease · 17
Ten-day vonoprazan–amoxicillin dual therapy versus 14-day esomeprazole–amoxicillin dual therapy for first-line Helicobacter pylori eradication: a prospective multicenter randomized controlled trial
2024 · Ben-Gang Zhou, Ming-Wen Guo, et al. · Therapeutic Advances in Gastroenterology · 16
Elevated bilirubin levels and risk of developing chronic kidney disease: a dose–response meta-analysis and systematic review of cohort studies
2017 · Jun Wang, Peng Guo, et al. · International Urology and Nephrology · 11
Efficacy and Safety of Tegoprazan–Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials
2026 · Ben‐Gang Zhou, Ye‐Min Xu, et al. · Journal of Gastroenterology and Hepatology · 9
PDF
Association between glaucoma and risk of stroke: A systematic review and meta-analysis
2023 · Meng Wang, Ni Chen, et al. · Frontiers in Neurology · 7
PDF
Non-alcoholic fatty liver disease and gestational diabetes mellitus: a bidirectional two-sample mendelian randomization study
2024 · Ben-Gang Zhou, Jian-Lei Xia, et al. · BMC Endocrine Disorders · 5
PDF
Association between metabolic dysfunction-associated steatotic liver disease and risk of incident pancreatic cancer: a systematic review and meta-analysis of cohort studies
2024 · Yi Zhang, Ben-Gang Zhou, et al. · Frontiers in Oncology · 4
Protective role of the planetary health diet index against metabolic dysfunction-associated steatotic liver disease: global and individual evidence
2025 · Zhuo-Qi Liu, Ben-Gang Zhou, et al. · Frontiers in Nutrition · 3
PDF
MAFF drives pancreatic cancer progression through AKR1C1-mediated inhibition of ferroptosis
2025 · Xin Jiang, Xuyu Chen, et al. · QJM · 2
Letter to the Editor: “Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta‐Analysis of Randomized Controlled Trials With Trial Sequential Analysis”
2025 · Ben‐Gang Zhou, Yao‐Yao Li, et al. · Helicobacter · 1
Prognostic risk factors analysis of low-grade gastric intraepithelial neoplasia—a single-center follow-up study
2025 · Xin Jiang, Ziting Miao, et al. · Frontiers in Medicine
PDF
Works count: 23
Citation count: 491
H-index: 14
I10-index: 15
Year
Topic
Type